[3] Zhang T, et al. The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions. Cancer Immunol Immunother. 2018;67(7):1079-1090.
[4] Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomized controlled trial[J]. Lancet, 2016, 79(3): 1540-1550.

• 新辅助免疫治疗发展如何？腔镜肺段切除有哪些技巧？这个大会将这些肺癌热点一网打尽
• 南昌大学第二附属医院消化内科2020年TIPS首破百例再创新高
• 新辅助化疗易导致耐药，癌症患者该如何选择？
• 红海之约，视觉盛宴，肖战王一博杨紫罗云熙加入星光大赏盛典